Rules on Embryos Proposed

MADRID—The Council of Europe, seeking a common framework for legislation regulating experiments on human embryos in its 21 member nations, is considering a new report by a Spanish physician on the ethics and biology of such research. In his report, Marcelo Palacios, a Socialist member of Spain’s parliament, endorses the increasingly accepted view that a fertilized human egg becomes an embryo 14 days after conception. The pre-embryo, he suggests, could be used for experimentation&

Written byMagdalena Ruiz
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

MADRID—The Council of Europe, seeking a common framework for legislation regulating experiments on human embryos in its 21 member nations, is considering a new report by a Spanish physician on the ethics and biology of such research.

In his report, Marcelo Palacios, a Socialist member of Spain’s parliament, endorses the increasingly accepted view that a fertilized human egg becomes an embryo 14 days after conception. The pre-embryo, he suggests, could be used for experimentation—but only with the explicit written consent of the donors of the reproductive material.

The Council of Europe’s Committee on Science and Technology will discuss Palacios’ report this month before sending it on to the Committee of Ministers. One year ago, the Council’s Assembly recommended that its member nations bar the creation of identical human beings by cloning or other methods, implantation of a human embryo in the uterus of an animal (or vice versa), genetic manipulation ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies